Back To Schedule
#218: Lessons Learned from Eight Years of Drug Development Tool/Novel Methodology Qualification
Chair
President and Chief Executive Officer, Critical Path Institute
Martha A. Brumfield, PhD, heads the Arizona-based non-profit in its mission to catalyze the development of new tools to advance medical product innovation and regulatory science. She has 20 years’ experience at Pfizer most recently as senior vice president of worldwide regulatory...
Read More →
Speakers
Director, Office of Translational Sciences, CDER, FDA
ShaAvhrée Buckman-Garner, MD, PhD, FAAP is the Director of the Office of Translational Sciences, Center for Drug Evaluation and Research (CDER), at the FDA. Prior to serving as Director of OTS, Dr. Buckman-Garner served as Deputy Director for OTS and as medical team leader in the...
Read More →
Head of International Affairs, European Medicines Agency, European Union
Ms. Cooke holds a MSc in Pharmaceutical Chemistry and an MBA from Trinity College, Dublin. Emer joined EMA as Head of Inspections in Jul. 2002. In Jan. 2009, Emer was appointed first International Liaison Officer for EMA. In July 2012 becomes the Head of Int. and European Cooperation...
Read More →
Tuesday June 28, 2016 10:30am - 11:30am EDT
201B
Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA
Trk 08: Reg Affairs,
Forum
- Credit Type ACPE, CME, IACET, RN
- Audience Intermediate
- Featured Topics Partnership Strategies, Clinical Trial Transparency-Clinical Trial Disclos, Increasing Research and Development Innovation, Design Thinking, Approval Pathways
- Interest Area Regulatory Affairs, R&D - Strategic Issues, Clinical Safety & Pharmacovigilance
- format json
- Interest Area Regulatory Affairs,R&D / Strategic Issues,Clinical Safety & Pharmacovigilance
- Featured Topics Partnership Strategies,Clinical Trial Transparency/Clinical Trial Disclos,Increasing Research and Development Innovation,Design Thinking,Approval Pathways
- Credit Type ACPE, CME, IACET, RN
- Tags Forum